XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,278,000 | -0.5% | 42,000 | 0.0% | 0.02% | +72.7% |
| Q1 2022 | $1,284,000 | -23.3% | 42,000 | -21.6% | 0.01% | -21.4% |
| Q4 2021 | $1,674,000 | +103.4% | 53,600 | 0.0% | 0.01% | +133.3% |
| Q3 2021 | $823,000 | -50.8% | 53,600 | -64.6% | 0.01% | -84.6% |
| Q3 2020 | $1,674,000 | -11.7% | 151,235 | 0.0% | 0.04% | -31.6% |
| Q2 2020 | $1,896,000 | +10.6% | 151,235 | 0.0% | 0.06% | -28.8% |
| Q1 2020 | $1,715,000 | -13.5% | 151,235 | +0.0% | 0.08% | +40.4% |
| Q4 2019 | $1,982,000 | +46.8% | 151,206 | 0.0% | 0.06% | +9.6% |
| Q3 2019 | $1,350,000 | -8.6% | 151,206 | +1.0% | 0.05% | -16.1% |
| Q2 2019 | $1,477,000 | +1.2% | 149,758 | +4.3% | 0.06% | -7.5% |
| Q1 2019 | $1,459,000 | +136.1% | 143,607 | +46.5% | 0.07% | +148.1% |
| Q4 2018 | $618,000 | – | 98,007 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |